Published in MD Week, September 2nd, 2005
"The majority of premature infants develop eosinophilia and abnormalities in eosinophil trafficking during the first period of postnatal life. We therefore thought to assess the ability of neonatal eosinophils to transmigrate in vitro toward chemotactic stimuli mimic either bacterial infections, or to allergic inflammation in vivo, and to compare the results with eosinophils in adults," wrote A. Moshfegh and colleagues, Karolinska University Hospital.
"We used an in vitro...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.